Vaccination programmes have also been disrupted by violent conflict. For example, aid
agencies have been unable to distribute COVID-19 vaccines, among other vaccines, in …

Dealing with vaccine equity and at the same time ensuring adequate protection for the most
vulnerable is essential to reduce the burden of COVID-19. New questions have been …

India has been gravely struck by the second wave of COVID-191 caused by SARS-CoV-2,
and is predicted to be hit by the third wave in the next few months. It is challenging for the …

The debate on COVID-19 vaccine equity has been longrunning, and we have previously
weighed in on the topic. However, the facts that (1) by Aug 9, only 12· 6 million of the 4· 46 …

Just a few weeks ago, more than half of the world's population was on lockdown to limit the
spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Scientists are …

In The Lancet Infectious Diseases, Eric Haas and colleagues1 estimated the benefits of the
rapid mass roll-out of the Pfizer–BioNTech vaccine in Israel between Dec 20, 2020, and …

On May 27, 2021, the WHO Strategic Advisory Group of Experts on Immunization (SAGE)
convened to discuss COVID-19 vaccines. 15 vaccines are currently in use (the Oxford …

As of Feb 8, more than 6 million people have been vaccinated in the world's largest COVID-
19 vaccination campaign that started on Jan 16 in India. The first vaccine was administered …

As the pandemic of coronavirus disease 2019 (COVID-19) continues to thread its way
around the globe, disruptions are occurring in healthcare, commerce, and travel, with …

More than 200 COVID-19 vaccines are in development worldwide, with governments
securing deals to access advance doses. But access is only one issue. Willingness to accept …